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Edited by Jesus AvilaAbstract ADP-ribosyl cyclase activity in the crude membrane
fraction of neuroblastoma · glioma NGPM1-27 hybrid cells
was measured by monitoring [3H] cyclic ADP-ribose (cADPR)
formation from [3H] NAD+. Bradykinin (BK) at 100 nM in-
creased ADP-ribosyl cyclase activity by about 2.5-fold. Applica-
tion of 300 nM BK to living NGPM1-27 cells decreased NAD+
to 78% of the prestimulation level at 30 s. In contrast, intracel-
lular cADPR concentrations were increased by 2–3-fold during
the period from 30 to 120 s after the same treatment. Our results
suggest that cADPR is one of the second messengers down-
stream of B2 BK receptors.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Bradykinin1. Introduction
Bradykinin (BK) plays an important role in blood pressure
control, inﬂammation, edema, pain, and neuronal signaling
[1]. Recently, BK was shown to be involved in the pathogenesis
of particular conditions, such as cardiovascular diseases and
glomerular injury in diabetes [2], prostate cancer [3], breast
cancer [4], tumor-associated angiogenesis [5], and Alzheimer’s
disease [6]. These physiological and pathophysiological eﬀects
of BK are exerted through BK receptors, B1 and B2 [1]. Stim-
ulation of BK receptors leads to activation of phospholipase CAbbreviations: BK, bradykinin; PLC, phospholipase C; InsP3, inositol-
1,4,5-trisphosphate; CICR, Ca2+-induced Ca2+ release; cADPR, cyclic
ADP-ribose; mAChR, muscarinic acetylcholine receptor; ADPR,
ADP-ribose; ACh, acetylcholine; CCh, carbamyocholinc; [b-NAD+]i,
intracellular b-NAD+ concentrations; [cADPR]i, intracellular cADPR
concentrations
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doi:10.1016/j.febslet.2006.07.084(PLC) [1,7], focal adhesion kinase [8], Pyk2 [9], protein kinase
C [10], and Ras or mitogen activated protein kinase [1,9]. BK
also activates Ca2+ processes due mainly to intracellular Ca2+
mobilization by inositol-1,4,5-trisphosphate (InsP3) from the
endoplasmic reticulum [1,7,10].
Ca2+ mobilization is triggered not only by InsP3 but also by
Ca2+ itself, i.e. Ca2+-induced Ca2+ release (CICR) via ryano-
dine receptors [11]. CICR is co-activated by a putative second
messenger, cyclic ADP-ribose (cADPR) [11–13]. cADPR is syn-
thesized from b-NAD+ by both membrane-bound and cytosolic
ADP-ribosyl cyclases in mammalian tissues, including the ner-
vous system [14]. The cADPR synthetic activity is regulated by
receptor stimulation with several diﬀerent mechanisms [12–14].
In one such mechanism, ADP-ribosyl cyclase seems to be cou-
pled directly with neurotransmitter or hormone receptors via
diﬀerent G proteins on the membrane surface [15]. However,
the same control of ADP-ribosyl cyclase by BK receptors has
not been reported previously. Recently, it was demonstrated
that BK increased intracellular calcium, nitric oxide, and
cADPR levels, and ADP-ribosyl cyclase activity in coronary
arterial endothelial cells subsequently causing smooth muscle
dilatation [16]. If this is true, it should be proved that BK de-
creases intracellular NAD+ levels as a consequence of ADP-
ribosyl cyclase activation. To address this question, we used a
neuronal model cell line of NGPM-1 neuroblastoma · glioma
hybrid cells, expressing endogenous B2 BK receptors and exog-
enous M1 muscarinic acetylcholine receptors (mAChRs)
[17,18]. We measured ADP-ribosyl cyclase activity in crude
membrane fractions of NGPM1-27 cells and showed changes
in the content of [3H] NAD+ and [3H] cADPR in reaction mix-
tures. Furthermore, to conﬁrm the signaling from B2 to ADP-
ribosyl cyclase in vivo, the substrate and product concentra-
tions, i.e., intracellular NAD+ and cADPR levels, were mea-
sured before and after application of BK ontoNGPM1-27 cells.2. Materials and methods
2.1. Membrane preparation
NGPM1-27 cells were cultured as described previously [17]. The cells
harvested were suspended in 10 mM Tris–HCl solution, pH 7.3, with
5 mM MgCl2 at 4 C for 30 min. The suspension was homogenizedblished by Elsevier B.V. All rights reserved.
4858 H. Higashida et al. / FEBS Letters 580 (2006) 4857–4860in a glass homogenizer. The resultant homogenate was centrifuged at
4 C for 5 min at 1000 · g to remove unbroken cells and nuclei. Crude
membrane fractions were prepared by centrifugation (twice) of homo-
genates at 105000 · g for 15 min. The supernatant was removed, and
the ﬁnal pellet was dispersed in 10 mM Tris–HCl solution, pH 7.0.
In each experiment, membranes were freshly prepared and used imme-
diately for enzymatic reactions.
2.2. ADP-ribosyl cyclase assay
Each 20-ll reaction mixture contained 50 mM Tris–HCl (pH 7.0);
100 mM KCl; 10 lM CaCl2; 2 lM b-NAD
+; 0.1 lM b-[2,8 ade-
nine-3H] NAD+ (0.06 lBq) and 0.40–7.16 lg of membrane proteins,
according to a formula reported previously [15]. Reaction mixtures
were incubated for 0.5–4 min at 37 C. Reactions were stopped by add-
ing 2 ll of 10% trichloroacetic acid, and aliquots were centrifuged for
1 min at 2100 · g, and 2 ll of the supernatant were spotted on silica gel
plastic thin layer sheets (20 · 10 cm). The layers were developed in the
ascending direction for 40–70 min at 23 C with a mixture of water/eth-
anol/ammonium bicarbonate (in the ratio 30%: 70%: 0.2 M or 36%:
64%: 0.3 M. The positions of authentic cADPR, ADP-ribose (ADPR)
and b-NAD+ were detected by UV illumination and of [3H]-labeled
products were autoradiographically conﬁrmed in each by Fuji Bas
1000 (Tokyo, Japan). Corresponding areas (about 1 · 0.7 cm) were
cut out and the radioactivity was counted in a liquid scintillation coun-
ter.
2.3. Intracellular NAD+ content
NGPM1-27 cells were cultured on polyornithine-coated dishes (35-
mm in diameter) for 4 days. The NAD+ content in the supernatant
of the heat-inactivated cell homogenate was determined by a slight
modiﬁcation of an enzyme cycling method described as reported previ-
ously [15].
2.4. Cycling assay for cADPR
Intracellular cADPR concentrations were measured according to
the enzyme cycling assay method described by Graeﬀ and Lee [19].
Brieﬂy, NGPM 1-27 cells were cultured in polyornithine-coated 35-
mm dishes. The cells were extracted with 100 ll of 0.6 M perchloric
acid at 4 C. In order to observe the agonist eﬀect on cADPR levels,
agonists were applied on cells in dishes with serum-containing growth
medium with no prior change to a fresh experimental medium without
serum.0
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3.1. Eﬀects of bradykinin on ADP-ribosyl cyclase activity in
NGPMl-27 cells
[3H] cADPR and [3H] ADPR were produced from b-[3H]
NAD+ by preparation of the crude membrane fraction of
NGPM1-27 cells. During an incubation period of 4 min, the
majority of radioactivity of b-NAD+ was converted to ADPR
and/or cADPR, as shown in Fig. 1. The accumulation of
radioactivity was greater in the spot of ADPR than cADPR
(Fig. 1A). The average speciﬁc activity of ADP-ribosyl cyclase,
as the rate of [3H] cADPR formation, was 204 ± 43 pmol/min/
mg protein (mean ± S.E.M., n = 27).
Addition of 100 nM BK to the reaction mixture at zero time
increased the rate of [3H] cADPR formation to a greater extent
than [3H] ADPR production (Fig. 1C). The average activation
by 100 nM BK was 248 ± 47% (n = 4) of the control activity
(Student’s t test, P < 0.01).
Next, we conﬁrmed the response to muscarinic receptors.
A similar level of stimulation (321 ± 41% (n = 4)) by 1 lM
carbamylcholine (CCh) of ADP-ribosyl cyclase was obtained
(321 ± 41%, n = 3; Fig. 1B and C).
3.2. BK-induced decrease in intracellular b-NAD+ concentration
To conﬁrm the above eﬀects of BK in vivo, we examined
agonist-stimulated changes in substrate levels (Fig. 2).
Fig. 2A shows the time course of changes in intracellular b-
NAD+ concentrations ([b-NAD+]i) in NGPM1-27 cells
challenged with 300 nM BK. [b-NAD+]i was signiﬁcantly de-
creased for 15–60 s after application of BK. The decrease in
[b-NAD+]i at 30 s was 77.3 ± 3.0% (n = 9,P < 0.01) of the
pre-stimulation level, and showed partial recovery at 120 s.
3.3. Intracellular cADPR concentrations in NGPM-1 cells
Intracellular cADPR concentrations ([cADPR]i) were mea-
sured by enzyme recycling assay. [cADPR]i in NGPM 1-270 60 120
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Fig. 2. BK-induced change in [NAD+]i and [cADPR]i; in intact
NGPM1-27 cells. (A) Time course of intracellular concentrations of
NAD+ ([NAD+]i). The growth medium was replaced with 2 ml of 10-
mM Tris–buﬀered Dulbecco’s modiﬁed Eagle’s medium and incubated
for 40 min at 37 C. The preincubated cells were then stimulated by
gently adding 1 ml of medium alone (none) or with 300 lM BK for the
indicated periods. Incubation was stopped by replacing the medium
with 1 ml of cold PBS and washed again with 1 ml PBS with 10 mM
nicotinamide. Cells were scraped, and the homogenates were heat-
inactivated. [NAD+]i was measured as described in Section 2. The
control value for the NAD+ level in NGPM1-27 cells was 4.9 ±
0.4 nmol/106 cells. (B) Time course of intracellular concentrations of
cADPR ([cADPR]i). Cells were grown in 35-mm culture dishes for 4
days. Two milliliter of the growth medium was replaced one day before
the experiments. Aliquots of 20 ll of 30 lM BK or phosphate buﬀer
(PBS) were added to the medium and incubated for the indicated
periods. The medium was removed and incubation was stopped by
adding 200 ll of 0.6 M perchloric acid. Cell lysate was collected and
centrifuged. The supernatant was used for measurement of cADPR
concentrations as described in Section 2. Values represent the
means ± S.E.M of three dishes in triplicate cultures. *, #, Signiﬁcantly
diﬀerent from the control value at time 0 at P< 0.05 and 0.01,
respectively.
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[cADPR]i; increased to 1225 ± 116 fmol/mg protein after
120 s with application of 300 nM BK onto NGPM 1-27 cells
(n = 4,P < 0.01) (Fig. 2B), and recovered to the control level
after 5 min. The BK-induced increase was blocked by prior
incubation of cells for 2 min with 1 lM [Thi5,8, D-Phe7]-brady-[c
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Fig. 3. Eﬀects of B2 antagonists on bradykinin-induced elevation of
intracellular cADPR concentrations in intact NGPM1-27 cells. Intra-
cellular cADPR concentrations ([cADPR]i) were measured in the
presence or absence of 100 nM BK with or without 1 lM or D-
Arginyl[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin (Hoe) or [Thi5,8, D-Phe7]-
bradykinin ([The]). Each data point represents the means ± S.E.M. of
4 determinations. *, # Signiﬁcantly diﬀerent from the control value or
the value with BK at P < 0.01, respectively.kinin or D-Arg-inyl-[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin
(Hoe140), both of which are B2-selective antagonists (Fig. 3).4. Discussion
The results of the present study indicated that BK and ACh
activates ADP-ribosyl cyclase in crude membrane preparations
of NGPM1-27 cells where B2 and M1 and M4 muscarinic
receptors are expressed [18]. In addition, we showed that BK
increased the intracellular cADPR production associated with
the intracellular decrease in NAD+. This is the ﬁrst demonstra-
tion of the converse of the substrate and product concentration
changes as a result of ADP-ribosyl cyclase activation after
receptor stimulation in living cells. The results suggest that
cADPR is one of the second messengers acting downstream
of BK receptors, in addition to InsP3 [7], at least in neuroblas-
toma hybrid cells.
B2 BK receptors as well as M1 mAChRs are expressed in in-
tact sympathetic neurons, and stimulation of these two types
of receptor leads to PLC-mediated production of InsP3 [1].
In neurons it has been shown that stimulation of B2 receptors
raises intracellular Ca2+ more eﬃciently than mAChRs, sug-
gesting the presence of a special membrane-transducing micro-
domain [20]. In such microdomain, InsP3-dependent Ca
2+
activates neuronal calcium sensor 1, phosphatidyl-4-kinase or
phosphatidyl-5-kinase, and thus produces more inositol-
4,5bisphosphate in the membranes [21,22]. Since we showed
that B2 receptors couple with ADPribosyl cyclase, it is possible
that the cADPR/ryanodine receptor signal may also make a
contribution in the microdomain complex. It will be necessary
to demonstrate the eﬀects of cADPR/ryanodine receptor-
dependent Ca2+ on neuronal function, such as Ca2+ and K+
currents, in future studies.
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